Alijotas-ReigJ. Treatment of refractory obstetric antiphospholipid syndrome: The state of the art and new trends in the therapeutic management. Lupus2013; 22: 6–17.
2.
BontadiARuffattiAMarsonP. Plasma exchange and immunoadsorption effectively remove antiphospholipid antibodies in pregnant patients with antiphospholipid syndrome. J Clin Apher2012; 27: 200–204.
3.
Gómez-PuertaJACerveraREspinosaG. Catastrophic antiphospholipid syndrome during pregnancy and puerperium: Maternal and fetal characteristics of 15 cases. Ann Rheum Dis2007; 66: 740–746.
4.
DeeksED. Certolizumab pegol: A review of its use in the management of rheumatoid arthritis. Drugs2013; 73: 75–97.
5.
MahadevanUWolfDCDubinskyM. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol2013; 11: 286–292.
6.
SchnitzlerFFidderHFerranteM. Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy. Inflamm Bowel Dis2011; 17: 1846–1854.
7.
VerstappenSMKingYWatsonKDSymmonsDPHyrichKL. Anti-TNF therapies and pregnancy: Outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register. Ann Rheum Dis2011; 70: 823–826.
8.
Pons-EstelGJSalerniGESerranoRM. Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: Report of 31 cases and review of the literature. Autoimmun Rev2011; 10: 679–684.
9.
Gómez-PuertaJEspinosaGCerveraR. Catastrophic antiphospholipid syndrome: Diagnosis and management in pregnancy. Clin Lab Med. Epub ahead of print 22 April 2013.
10.
El-HaiegDOZanatiMFEl-FoualFM. Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome. Int J Gynaecol Obstet2007; 99: 236–241.
